Newron Pharmaceuticals S.p.A.: Newron Announces 2022 Financi

Ad hoc announcement pursuant to Art. 53 LR Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients

Related Keywords

Germany , Seika , Kyongsang Bukto , South Korea , Australia , Japan , Milan , Lombardia , Italy , United States , United Kingdom , Israel , United Arab Emirates , Canada , Switzerland , America , Swiss , Dennis Riedl , Patrick Langlois , Bresso Mi , Antonio Meucci , Stefan Weber , Valentin Handschin , Anne Hennecke Caroline Bergmann , Paul Sagan , Luca Benatti , Glaxosmithkline , Mc Services , Head Of Research , University Of Surrey , Dusseldorf Stock Exchange , Early Development At Jazz Pharmaceuticals , Newron Pharmaceuticals , Drug Administration , Swiss Exchange , Gw Pharmaceuticals , European Union , Sustainable Development Goals , University Of Leeds , Supernus Pharmaceuticals , Abbreviated New Drug Applications , Development Goals , Negative Syndrome Scale , Clinical Global Impression Severity , Clinical Global Impression Change , Latin America , Abbreviated New Drug Application , Drugs Product List , Orange Book , Annual Report , Meeting Agenda , Via Antonio Meucci , Gillian Dines , Senior Vice President , Early Development , Company Director , Chief Development Officer , Meiji Seika , Conway Ciara Martin Natalie Garland Collins , Hennecke Caroline Bergmann , Onewron , Pharmaceuticals , Nnounces , 022 , Financial , Results , Rovides , Outlook , 023 ,